BioWorld

April 4, 2005

View Archived Issues

Alkermes' Alcohol Dependence Drug Vivitrex On File With FDA

Alkermes Inc. applied for FDA approval of Vivitrex (naltrexone long-acting injection) to treat alcoholism, making it the first injectable product filed for the indication. (BioWorld Today) Read More

Progenics Raising $30M For MNTX, HIV, Cancer Programs

Read More

Cephalon Files For Approval Of Next Generation Provigil

Read More

Exelixis Drops Ag Joint Venture, Gets $21M To Focus On Pipeline

Read More

Other News To Note

Read More